Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

Completed

Conditions studied: DCIS, Invasive Breast Cancer

In brief

Microorganisms in the human body (such as virus, bacteria, fungus) may have an important role in breast cancer side effects. In this study, microorganisms will be analyzed to determine which, if any,are present. It will then be determined if side effects from breast radiation are associated with these microorganisms. Understanding the association of microorganisms with side effects will allow the study team to look at strategies to reduce side effects for patients undergoing radiation to the breast.

Key facts

Study ID

NCT04245150

Run by

Case Comprehensive Cancer Center

People needed

23

Starts

2019-03-21

Expected to finish

2024-07-30

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer patients with DCIS or invasive breast cancer
• Undergoing breast conserving surgery and adjuvant radiation
• Subjects must be willing and able to provide breast skin samples

You may not qualify if…

• Active clinical breast infection (on antiobiotic for skin/breast infection or clinical diagnosis)
• Refuse or are unable to sign informed consent form
• Past history of breast cancer

Where it is running

• Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.